On September 7, 2021 Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, reported that its Chief Executive Officer, Nancy Simonian, M.D., will present a corporate overview at two upcoming investor conferences in September (Press release, Syros Pharmaceuticals, SEP 7, 2021, View Source [SID1234587335]). Management will also be available for one-on-one meetings.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
H.C Wainwright 23rd Annual Global Investment Conference
Date: Monday, September 13
Time: A pre-recorded presentation will be made available beginning at 7:00 a.m. ET.
Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Date: Wednesday, September 22
Time: 2:05 p.m. ET
To access the webcasts and subsequent archived recording of each presentation, please visit the Investors & Media section of the Syros website at www.syros.com. An archived replay of each webcast will be available for approximately 30 days following each presentation.